Drawing for DG

USPTO serial 97774238

DG

Reviewed by CopyMark Law Group

Reg. 7839376Status 700Registered
Filing date
Status date
Registration date
Jun 24, 2025
Examiner
ROSSMAN, WILLIAM M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristin Grant

Kristin Grant GRANT ATTORNEYS AT LAW PLLC1185 6th Avenue, 3rd FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medical preparations for prevention and treatment of cardiovascular, brain, nervous system, endocrine, immune system, ophthalmic, digestive system, excretory, respiratory system, renal, reproductive system, sensory, muscular system, skeletal system, pain, eye, ear, nose, hair, dermal, kidney, liver, pancreas, dental, buccal, pediatric, gynecological, congenital, blood, prostate, and psychiatric related diseases and disorders; Pharmaceutical and medical preparations for prevention and treatment of cancer, diabetes, asthma, depression, hypertension, schizophrenia, Parkinson's, and bipolar disorder, infectious diseases, due to bacteria, virus, fungus, and protozoa, tuberculosis, stroke, diarrhea, osteoporosis, arthritis, obesity, and allergies; Pharmaceutical and medical preparations for use in anesthesia and radiotherapy; Pharmaceutical and medical preparations for medical imaging purposes; Pharmaceutical and medical preparations for nutritional purposes; Veterinary preparations for cows, buffalos, cats, dogs, horses, pets, camels, birds, goats, sheep, chickens, rabbits, fish for treatment of infectious diseases due to bacteria, viruses, worms and other microorganisms; Veterinary preparations for the prevention and treatment of cardiovascular, brain, nervous system, endocrine, immune system, ophthalmic, digestive system, excretory, respiratory system, renal, reproductive system, sensory, muscular system, skeletal system, pain, eye, ear, nose, hair, dermal, kidney, liver, pancreas, dental, buccal, pediatric, gynecological, congenital, blood, and prostate related diseases and disorders; Sanitary preparations for medical purposes; Dietetic preparations adapted for medical purposes; Dietetic foods adapted for medical use; Dietetic foods adapted for veterinary use; Dietetic substances adapted for medical use; Dietetic substances adapted for veterinary use; Food for babies; Dietary supplements for human beings and animals; Plasters for medical purposes; Medical and surgical dressing; Material for stopping teeth; Dental waxes; Disinfectants; Preparations for destroying vermin; Fungicides; HerbicidesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 26, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 26, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 26, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 26, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 26, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 24, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 24, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 6, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 6, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 30, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 16, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 16, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 8, 2025OTHECASE RETURNED TO EXAMINATION—
Apr 8, 2025IUCNNOTICE OF ALLOWANCE CANCELLED—
Apr 8, 2025PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Mar 27, 2025ERTITEAS RESPONSE TO PETITION INQUIRY LETTER—
Feb 26, 2025PILMPETITION INQUIRY LETTER ISSUED—
Nov 14, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 14, 2024EX1GSOU EXTENSION 1 GRANTED—
Nov 14, 2024EXT1SOU EXTENSION 1 FILED—
Nov 14, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 14, 202444EP44(e) PETITION - RECEIVED—
Jun 14, 2024EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
May 14, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 3, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 3, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 28, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 6, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
May 16, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 16, 2023GNSLLETTER OF SUSPENSION E-MAILED—
May 16, 2023CNSLSUSPENSION LETTER WRITTEN—
May 8, 2023DOCKASSIGNED TO EXAMINER—
Feb 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 3, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance